Home › Funds › Alyeska Investment Group, L.P. › CVS

Alyeska Investment Group, L.P. position in CVS

CVS HEALTH CORP · Consumer Staples

Alyeska Investment Group, L.P. reported holding 1,685,440 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$174.4M, representing 0.45% of its reported portfolio and ranking #50 among its reported holdings. Alyeska Investment Group, L.P. has disclosed CVS holdings in 3 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)1.69M sh
Reported value held$174.36M
Portfolio Weight0.45%
First reportedQ2 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alyeska Investment Group, L.P.'s CVS position evolved

Alyeska Investment Group, L.P. first disclosed a stake in CVS in Q2 2024 at 1,014,191 shares (US$59.9M). The position peaked in Q2 2026 at 1,685,440 shares, worth US$174.4M. Across 3 filings, Alyeska Investment Group, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,685,440 shares valued at US$174.4M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.01M $59.90M New
Q4 2025 795.00K $63.09M New
Q2 2026 1.69M $174.36M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Alyeska Investment Group, L.P. held CVS?

Alyeska Investment Group, L.P. has disclosed CVS holdings in 3 of the last 9 reported quarters, going back to Q2 2024.

What is Alyeska Investment Group, L.P.'s current position in CVS?

As of Q2 2026, Alyeska Investment Group, L.P. holds 1.69M shares of CVS (CVS HEALTH CORP), valued at $174.36M, representing 0.45% of its reported portfolio and ranking #50.

Has Alyeska Investment Group, L.P. been buying or selling CVS?

In the latest 13F filing (Q2 2026), Alyeska Investment Group, L.P. newly opened its position in CVS. The position peaked in Q2 2026 at 1.69M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.